Articles

Original Research

10.4244/EIJ-D-23-00722 • Jan 15, 2024
Impact of transcatheter heart valve type on outcomes of surgical explantation after failed transcatheter aortic valve replacement: the EXPLANT-TAVR international registry
Zaid S, Kleiman N, Goel SS, Szerlip MI, Mack MJ, Marin-Cuartas M, Mohammadi S, Nazif TM, Unbehaun A, Andreas M, Brinster DR, Robinson NB, Wang L, Ramlawi B, Conradi L, Desai N, Forrest JK, Bagur R, Nguyen TC, Waksman R, Leroux L, Van Belle E, Grubb KJ, Ahmad H, Denti P, Modine T, Bapat VN, Kaneko T, Reardon MJ, Tang GH, EXPLANT-TAVR registry investigators obot
free

Original Research

10.4244/EIJ-D-23-00469 • Jan 15, 2024
Contemporary guideline-directed management of patients with severe aortic valve stenosis
Wang X, Arslani K, Nuyens P, Montarello N, Vanhaverbeke M, Bieliauskas G, Sondergaard L, De Backer O
free

EAPCI Column

Jan 15, 2024
EAPCI Focus on the EAPCI Gender and Disparities Committee
free

Trial Design

10.4244/EIJ-D-23-00567 • Jan 10, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Pathimagaraj RH, Nijjer S, Sen S, Petraco R, Clesham G, Johnson T, Harrell Jr FE, Kellman P, Francis D, Shun-Shin M, Howard J, Cole G, Al-Lamee R
free

Letter to the editor

10.4244/EIJ-D-23-00830 • Jan 1, 2024
Letter: Due to the lack of significant mortality benefit along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged
Movahed MR
free

Reply to the letter to the editor

10.4244/EIJ-D-23-00857 • Jan 1, 2024
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged
Werner G, Hildick-Smith D
free

EAPCI Column

Jan 1, 2024
EAPCI membership: why should you become an EAPCI member? Message from Emanuele Barbato, EAPCI President
free

Editorial

Jan 1, 2024
EuroIntervention: the dawn of a new era
Capodanno D
free

Editorial

10.4244/EIJ-E-23-00062 • Jan 1, 2024
Hybrid coronary revascularisation: the best or the worst of both worlds?
Gaudino M, Sandner S
free

Editorial

10.4244/EIJ-E-23-00064 • Jan 1, 2024
Robotic-assisted percutaneous coronary intervention: the future or the past?
Durand E, Eltchaninoff H
free

Editorial

10.4244/EIJ-E-23-00051 • Jan 1, 2024
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis
Gargiulo G, Giacoppo D
free

Editorial

10.4244/EIJ-E-23-00056 • Jan 1, 2024
The first cut is the deepest – a solution for treating calcified lesions?
Mashayekhi K, Moos S
free

Editorial

10.4244/EIJ-E-23-00058 • Jan 1, 2024
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial
Windecker S, Tomii D
free

Debate

10.4244/EIJ-E-23-00023 • Jan 1, 2024
Observational studies play little role in guiding evidence-based medicine: pros and cons
Steg P, Feldman L, Omerovic E
free

State-of-the-Art

10.4244/EIJ-D-23-00606 • Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R, Merdler I, Case BC, Waksman O, Porto I
free
Receive our newsletter
PCR
Readers
Current issue
Archives
Subscriptions
Authors
Submit your paper
Instructions
Services
Advertise
Reprints / ePrints
Rights and permissions
Textbooks
The PCR Textbook
The history of angioplasty
Percutaneous cardiac interventions
About the journal
Editorial team
Disclaimer
Legal notice
Privacy policy
Cookie Management
Follow us
Facebook
X
Instagram
LinkedIn
YouTube
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved